01 1AbbVie Inc
02 1DURATA THERAPS INTL
03 1Duration Therapeutics
01 1Dalbavancina 500Mg 1 Unit Parenteral Use
02 1POWDER FOR CONCENTRATE FOR
03 1POWDER;INTRAVENOUS
01 1RX
02 2Blank
01 1DALVANCE
02 2Xydalba
01 1Italy
02 1Sweden
03 1USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DALVANCE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 500MG BASE/VIAL
Packaging :
Approval Date : 2014-05-23
Application Number : 21883
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Xydalba
Dosage Form : Dalbavancina 500Mg 1 Unit Parenteral Use
Dosage Strength : 1 bottle groun EV 500 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Sweden
Brand Name : Xydalba
Dosage Form : POWDER FOR CONCENTRATE FOR
Dosage Strength : 500 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?